Literature DB >> 7770600

Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats.

S I Dworkin1, S Gleeson, D Meloni, T R Koves, T J Martin.   

Abstract

The effects of ibogaine (40 and 80 mg/kg, i.p.), an indole alkaloid proposed for the treatment of drug abuse, were determined in three different groups of rats responding under an FR10 schedule of food, cocaine or heroin reinforcement. Ibogaine (80 mg/kg, i.p.) given 60 min before the start of the session resulted in a 97% decrease in the number of ratios completed under the food reinforcement schedule and resulted in a decrease in responding the following day. Neither 40 mg/kg ibogaine given 60 min prior to the session nor 80 mg/kg given 24 h before the session suppressed responding maintained by cocaine infusions (0.33 mg/infusion). Pretreatment with 80 mg/kg ibogaine either 60 or 90 min prior to the session suppressed cocaine self-administration on the day it was administered and the longer pretreatment continued to suppress responding for 48 h. Responding maintained by heroin (18 micrograms/infusion) was the most sensitive to the effects of ibogaine. Both 40 and 80 mg/kg ibogaine resulted in an almost complete suppression of responding following a 60-min pretreatment period. Responding maintained by heroin returned to control levels the day following the administration of ibogaine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770600     DOI: 10.1007/bf02246099

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Inhibitory effects of ibogaine on cocaine self-administration in rats.

Authors:  S L Cappendijk; M R Dzoljic
Journal:  Eur J Pharmacol       Date:  1993-09-14       Impact factor: 4.432

2.  Ibogaine antagonizes cocaine-induced locomotor stimulation in mice.

Authors:  H Sershen; A Hashim; L Harsing; A Lajtha
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

3.  Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.

Authors:  I M Maisonneuve; R W Keller; S D Glick
Journal:  Brain Res       Date:  1992-05-01       Impact factor: 3.252

4.  Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

Authors:  I M Maisonneuve; S D Glick
Journal:  Eur J Pharmacol       Date:  1992-03-03       Impact factor: 4.432

5.  Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.

Authors:  H Sershen; L G Harsing; A Hashim; A Lajtha
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

6.  Ibogaine induces glial activation in parasagittal zones of the cerebellum.

Authors:  E O'Hearn; D B Long; M E Molliver
Journal:  Neuroreport       Date:  1993-03       Impact factor: 1.837

7.  Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

Authors:  I M Maisonneuve; R W Keller; S D Glick
Journal:  Eur J Pharmacol       Date:  1991-06-18       Impact factor: 4.432

8.  Effects and aftereffects of ibogaine on morphine self-administration in rats.

Authors:  S D Glick; K Rossman; S Steindorf; I M Maisonneuve; J N Carlson
Journal:  Eur J Pharmacol       Date:  1991-04-03       Impact factor: 4.432

9.  Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.

Authors:  E D Dzoljic; C D Kaplan; M R Dzoljic
Journal:  Arch Int Pharmacodyn Ther       Date:  1988 Jul-Aug

10.  Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

Authors:  I M Maisonneuve; K L Rossman; R W Keller; S D Glick
Journal:  Brain Res       Date:  1992-03-13       Impact factor: 3.252

View more
  5 in total

1.  Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption.

Authors:  Dao-Yao He; Nancy N H McGough; Ajay Ravindranathan; Jerome Jeanblanc; Marian L Logrip; Khanhky Phamluong; Patricia H Janak; Dorit Ron
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

2.  Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

Authors:  M E Benwell; P E Holtom; R J Moran; D J Balfour
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  EEG Gamma Band Alterations and REM-like Traits Underpin the Acute Effect of the Atypical Psychedelic Ibogaine in the Rat.

Authors:  Joaquín González; Matias Cavelli; Santiago Castro-Zaballa; Alejandra Mondino; Adriano B L Tort; Nicolás Rubido; Ignacio Carrera; Pablo Torterolo
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-11

Review 4.  Ibogaine and addiction in the animal model, a systematic review and meta-analysis.

Authors:  M Belgers; M Leenaars; J R Homberg; M Ritskes-Hoitinga; A F A Schellekens; C R Hooijmans
Journal:  Transl Psychiatry       Date:  2016-05-31       Impact factor: 6.222

Review 5.  Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.

Authors:  Nataliya Vorobyeva; Alena A Kozlova
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.